This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endovascular or surgical operations to intracerebral aneurysms
I9_ANEUR
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
2456 |
4. Check minimum number of eventsNone |
2456 |
5. Include endpointsNone |
2456 |
6. Filter based on genotype QC (FinnGen only) |
2456 |
Control definitions (FinnGen only)
- Control exclude
- I9_CEREBVASC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Endovascular or surgical operations to intracerebral aneurysms
based on the number of shared cases.
Similar with more cases:
- Aneurysms, operations, SAH
- Cerebrovascular diseases (FINNGEN)
- Cerebrovascular diseases
- Neurological diseases, wide definition
- Cardiovascular diseases (excluding rheumatic etc)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2456 | 1497 | 959 |
| Unadjusted period prevalence (%) | 0.48 | 0.51 | 0.42 |
| Median age at first event (years) | 53.39 | 53.35 | 53.47 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2283
- Matched controls
- 22831
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
+∞
323.0
442
*
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
1374.6
323.0
444
*
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
+∞
323.0
362
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
77.5
323.0
424
67
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
1322.7
323.0
514
5
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
323.0
1568
*
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
+∞
323.0
316
*
2161
FHL
Neck ligation, big brain
+∞
323.0
429
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
3611.0
323.0
575
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
16384.0
323.0
1212
*
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
+∞
323.0
626
*
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
+∞
323.0
307
*
AA1AD
NOMESCO Finland
CT of head and brain
6.2
296.5
1018
2640
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
128.1
273.7
291
26
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
112.4
272.8
294
30
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
+∞
198.9
188
*
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
+∞
192.5
182
*
AAF00
NOMESCO Finland
Ventriculostomy
162.9
185.7
194
13
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
+∞
182.8
173
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
617.3
175.9
172
*
N03AB02
ATC
phenytoin; systemic
37.6
164.7
212
62
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1722.8
162.4
156
*
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
77.2
152.1
172
24
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
9.4
143.4
314
381
4373A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured
+∞
127.3
121
*
ZXD05
NOMESCO Finland
Urgent procedure
3.1
124.1
959
4346
K90
ICPC
Stroke/cerebrovascular accident
40.8
118.1
149
39
G91.0
ICD-10 Finland
Communicating hydrocephalus
83.4
112.5
126
16
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
+∞
109.2
104
*
I60.6
ICD-10 Finland
Subarachnoid haemorrhage from other intracranial arteries
+∞
106.1
101
*
R51.80
ICD-10 Finland
Headache
3.9
104.0
497
1527
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
219.9
102.4
105
5
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
+∞
101.8
97
*
XA800
NOMESCO Finland
Neuropsychological investigation
10.0
98.1
204
221
AA9CW
NOMESCO Finland
NA
132.0
94.8
101
8
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
24.5
92.1
132
57
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
870.1
86.2
84
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
85.3
505
1809
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
+∞
82.8
79
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
8.8
82.1
183
223
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.1
79.5
527
2035
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
12.2
76.7
143
124
N03AF02
ATC
oxcarbazepine; oral
8.9
74.6
165
198
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
24.4
73.4
105
45
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
188.4
70.5
73
*
4309X
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS NUD]
+∞
70.2
67
*
B01AC04
ATC
clopidogrel; oral
3.1
68.6
433
1600
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.8
67.8
128
114
ZXE20
NOMESCO Finland
More than three and less than five hours
2.9
66.9
463
1815
K91
ICPC
Cerebrovascular disease
34.7
66.9
87
26
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
65.5
992
5912
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
120.3
65.2
70
6
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
6.2
63.8
181
313
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.3
63.4
159
232
N03AX14
ATC
levetiracetam; systemic
9.0
62.6
137
161
AA5PD
NOMESCO Finland
CT examination of brain pefusion
65.6
60.7
70
11
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.9
60.4
275
784
I60.4
ICD-10 Finland
Subarachnoid haemorrhage from basilar artery
+∞
58.6
56
*
205
Kela drug reimbursment
Chronic hypertension
2.2
57.4
757
4169
ZXM40
NOMESCO Finland
Use of fluorescent substance
153.9
57.1
60
*
C08CA06
ATC
nimodipine; systemic
293.8
56.5
57
*
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
55.4
53
*
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
30.9
54.0
72
24
I63.8
ICD-10 Finland
Other cerebral infarction
271.9
52.3
53
*
XCK00
NOMESCO Finland
Perimetry
3.7
52.3
249
734
H53.4
ICD-10 Finland
Visual field defects
10.1
52.2
106
109
PA2AD
NOMESCO Finland
CT angiography of brain
43.8
51.9
64
15
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
9.3
51.2
109
122
N03AF01
ATC
carbamazepine; oral, rectal
4.4
49.9
193
471
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
+∞
48.1
46
*
WW200
SPAT
NA
2.9
47.8
331
1275
R4150
NOMESCO Finland
Neuropsychological rehabilitation
27.4
46.6
64
24
Z2445
NOMESCO Finland
Psychologist
5.7
46.0
137
251
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
234.6
45.1
46
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
45.1
254
850
N18
ICPC
Paralysis/weakness
12.5
45.0
82
68
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
+∞
43.9
42
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
43.5
1399
10497
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
89.7
39.9
44
5
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
39.7
226
760
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
39.3
374
1716
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.3
37.8
146
355
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
37.6
36
*
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
12.0
37.4
69
59
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
101.8
36.8
40
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.3
35.6
191
614
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
352.4
35.0
35
*
43090
ICD-8 Finland
Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata
+∞
34.5
33
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
3.2
33.3
190
638
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
5.5
33.1
100
187
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
5.6
33.1
99
183
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
9.8
32.9
67
70
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
172.5
32.8
34
*
WX882
NOMESCO Finland
High dependency care
5.2
32.5
104
208
R42
ICD-10 Finland
Dizziness and giddiness
2.0
32.1
512
2926
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
44.0
31.9
39
9
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
16.3
31.6
51
32
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
37.0
31.5
40
11
PA2AG
NOMESCO Finland
Restrected MRI examination of vessels in the head with high intensity magnet
60.9
31.1
36
6
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
317.0
30.9
31
*
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
30.3
29
*
TAB00
NOMESCO Finland
Lumbar puncture
3.5
29.8
145
432
N03AG01
ATC
valproic acid; systemic, rectal
3.1
29.6
174
595
ZXD35
NOMESCO Finland
Usual procedure
4.1
29.4
119
303
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.5
29.0
248
1066
G44.2
ICD-10 Finland
Tension-type headache
2.2
29.0
319
1553
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
146.8
27.7
29
*
-
ICD-10 Finland
NA
4.6
27.6
98
220
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
11.1
27.3
52
48
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
19.4
26.5
40
21
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.9
26.2
48
41
C08CA01
ATC
amlodipine; oral
1.7
25.9
819
5764
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
13.2
25.2
44
34
I60.5
ICD-10 Finland
Subarachnoid haemorrhage from vertebral artery
+∞
25.0
24
*
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
+∞
25.0
24
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
24.5
381
2135
ZXA00
NOMESCO Finland
Right side
1.7
24.4
641
4263
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.5
24.1
208
896
I60
ICD-10 Finland
Subarachnoid haemorrhage
+∞
24.0
23
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.3
23.9
91
219
N02BE01
ATC
paracetamol; systemic, rectal
1.8
23.6
1931
17223
C09AA02
ATC
enalapril; systemic
1.8
23.4
448
2696
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
10.9
23.1
44
41
AAK00
NOMESCO Finland
Cranioplasty
65.6
22.9
26
*
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
232.2
22.7
23
*
3313A
ICD-9 Finland
Other cerebral degenerations, Communicating hydrocephalus
232.2
22.7
23
*
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
45.5
22.4
27
6
I67.0
ICD-10 Finland
Dissection of cerebral arteries, nonruptured
+∞
21.9
21
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
14.0
21.3
36
26
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
19.1
21.3
32
17
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
21.2
181
775
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
15.7
21.0
34
22
ZYC01
SPAT
NA
2.8
20.9
137
505
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
+∞
20.9
20
*
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
20.9
20
*
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
+∞
20.9
20
*
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
21.7
20.8
30
14
AAK80
NOMESCO Finland
Partial excision of skull cap
211.8
20.6
21
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
15.2
20.2
33
22
Z3231
NOMESCO Finland
Registered nurse
1.6
20.1
591
4018
AAF15
NOMESCO Finland
Ventriculoatrial shunt
29.2
19.6
26
9
G91.1
ICD-10 Finland
Obstructive hydrocephalus
19.6
19.5
29
15
SPAT1252
SPAT
Overall medication plan or its review
2.4
19.2
172
755
H53.2
ICD-10 Finland
Diplopia
3.8
19.0
81
218
R51
ICD-10 Finland
Headache
2.8
18.8
127
476
2132
FHL
Ventricular operators sunt
70.5
18.7
21
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.4
18.5
164
713
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
18.5
122
452
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
4.5
18.2
65
148
G40.10
ICD-10 Finland
Simple partial seizures
10.4
18.1
35
34
PA7BD
NOMESCO Finland
CT angiography of neck and brain
6.5
17.8
46
72
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
17.7
834
6313
183
Kela drug reimbursment
Lamotrigin and topiramate
8.6
17.7
38
45
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
29.0
17.4
23
8
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
4.8
17.2
57
121
N05BA09
ATC
clobazam; oral
14.2
16.8
28
20
PA7KT
NOMESCO Finland
Temporary closure of brain artery
+∞
16.7
16
*
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
15.2
16.7
27
18
WX320
NOMESCO Finland
Spinalanesthesy
0.5
16.6
204
3459
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.6
16.6
121
475
SPAT1216
SPAT
Assessment of functional ability
1.8
16.5
326
1963
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
171.2
16.5
17
*
B01AC07
ATC
dipyridamole; systemic
3.3
16.4
82
252
H53.1
ICD-10 Finland
Subjective visual disturbances
2.4
16.2
141
610
A28
ICPC
Limited function/disability NOS
1.8
16.1
299
1761
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.6
16.0
73
209
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.9
15.8
97
344
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
15.8
566
4006
Z00.0
ICD-10 Finland
General medical examination
1.7
15.7
380
2429
43099
ICD-8 Finland
Subarachnoid haemorrhage, Without mention of hypertension
+∞
15.6
15
*
2164
FHL
Crotigree
+∞
15.6
15
*
N28
ICPC
Limited function/disability (N)
5.6
15.6
45
82
C10AA01
ATC
simvastatin; oral
1.5
15.6
916
7206
C07AB02
ATC
metoprolol; systemic
1.6
15.4
441
2950
GBB00
NOMESCO Finland
Tracheostomy
5.8
15.0
42
74
Z3226
NOMESCO Finland
Physiotherapist
1.7
14.9
380
2459
G40
ICD-10 Finland
Epilepsy
7.5
14.7
34
46
AAC10
NOMESCO Finland
Reinforcement of intracranial aneurysm wall
+∞
14.6
14
*
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
+∞
14.6
14
*
R1250
NOMESCO Finland
Evaluation of functional capability
3.6
14.5
64
179
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
42.7
14.1
17
*
C09BA02
ATC
enalapril and diuretics; systemic
2.0
14.0
189
996
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
13.8
160
793
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.7
13.7
46
100
R1260
NOMESCO Finland
Evaluation of communicative skills
6.0
13.6
37
63
I69
ICD-10 Finland
Sequelae of cerebrovascular disease
75.6
13.6
15
*
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
+∞
13.6
13
*
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
+∞
13.6
13
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
13.5
597
4401
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
13.5
449
3105
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
5.5
13.4
39
72
C10AA05
ATC
atorvastatin; oral
1.4
13.4
782
6089
N19
ICPC
Speech disorder
7.8
13.4
30
39
C09CA01
ATC
losartan; oral
1.5
13.2
515
3693
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
8.6
13.2
28
33
M01AH05
ATC
etoricoxib; oral
0.7
13.2
906
10929
ZXY02
NOMESCO Finland
Neuropsychologist
12.2
13.1
23
19
ZXH06
SPAT
NA
3.2
13.0
68
218
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
13.0
133
625
SPAT1229
SPAT
Assessment of need for aid
2.0
12.7
176
936
N07BA03
ATC
varenicline; oral
2.4
12.6
107
459
C07AB07
ATC
bisoprolol; oral
1.4
12.6
975
7971
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
+∞
12.5
12
*
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
+∞
12.5
12
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.3
12.2
115
519
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
16.0
12.1
19
12
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.5
12.0
71
1511
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
21.4
12.0
17
8
Z2446
NOMESCO Finland
Social worker
2.1
12.0
131
635
P20
ICPC
Memory disturbance
1.8
11.9
232
1385
SPAT1276
SPAT
Outlining of treatment with patient or their family members
3.3
11.9
59
182
Z71.8
ICD-10 Finland
Other specified counselling
1.5
11.8
437
3090
N06AB10
ATC
escitalopram; oral
1.6
11.8
369
2510
ZXH09
SPAT
NA
3.4
11.7
55
163
RS340
NOMESCO Finland
NA
16.5
11.7
18
11
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
11.7
301
1951
I72.0
ICD-10 Finland
Aneurysm and dissection of carotid artery
30.2
11.6
15
5
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
+∞
11.5
11
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.8
11.4
184
1034
N05AH04
ATC
quetiapine; oral
1.6
11.4
300
1952
R4120
NOMESCO Finland
Occupational therapy
2.2
11.4
119
563
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
6.1
11.3
30
50
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
11.3
156
829
I72.8
ICD-10 Finland
Aneurysm and dissection of other specified arteries
10.6
11.3
21
20
315
Kela drug reimbursment
Clopidogrel
6.6
11.3
28
43
N03AX18
ATC
lacosamide; systemic
7.6
11.1
25
33
R55
ICD-10 Finland
Syncope and collapse
1.8
11.0
200
1171
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.9
11.0
66
234
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.9
10.9
157
847
Z94.0
ICD-10 Finland
Kidney transplant status
5.1
10.9
33
65
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.6
10.9
48
136
M03BX01
ATC
baclofen; systemic
3.8
10.9
45
121
N06AB04
ATC
citalopram; systemic
1.5
10.8
432
3100
R4130
NOMESCO Finland
Speech therapy
3.7
10.8
46
127
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
21.6
10.7
15
7
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
21.6
10.7
15
7
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
11.3
10.5
19
17
R41.0
ICD-10 Finland
Disorientation, unspecified
2.8
10.5
65
233
I62.1
ICD-10 Finland
Nontraumatic extradural haemorrhage
+∞
10.4
10
*
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
16.1
10.3
16
10
R20.2
ICD-10 Finland
Paraesthesia of skin
2.0
10.2
123
621
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
10.2
783
6324
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
0.4
10.1
41
999
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
10.1
578
4441
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
10.0
300
2013
G40.89
ICD-10 Finland
Other epilepsy
9.2
10.0
20
22
XX4AW
NOMESCO Finland
NA
40.2
10.0
12
*
OAB42
SPAT
NA
2.2
9.9
97
448
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
6.7
9.9
24
36
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
16.8
9.9
15
9
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
9.8
338
2346
S18
ICPC
Laceration/cut
1.3
9.7
834
6849
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
5.6
9.6
27
49
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
55.2
9.6
11
*
Z72.0
ICD-10 Finland
Tobacco use
2.8
9.6
58
207
C08CA02
ATC
felodipine; oral
1.7
9.6
191
1149
N88
ICPC
Epilepsy
7.8
9.6
21
27
A06AD11
ATC
lactulose; oral
1.6
9.6
272
1801
XA400
NOMESCO Finland
EEG
6.8
9.6
23
34
SPAT1301
SPAT
No procedures
1.4
9.6
612
4787
G41.9
ICD-10 Finland
Status epilepticus, unspecified
9.1
9.5
19
21
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.9
9.4
145
804
I61
ICD-10 Finland
Intracerebral haemorrhage
100.4
9.4
10
*
G81.1
ICD-10 Finland
Spastic hemiplegia
30.1
9.4
12
*
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
+∞
9.4
9
*
J67.1
ICD-10 Finland
Bagassosis
+∞
9.4
9
*
SPAT1254
SPAT
Administration of medicine
1.6
9.3
263
1738
A02BC03
ATC
lansoprazole; oral
1.4
9.3
605
4745
N05BA04
ATC
oxazepam; oral
1.4
9.2
476
3580
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.9
9.2
36
93
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.3
9.2
45
140
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
13.7
9.2
15
11
G45.3
ICD-10 Finland
Amaurosis fugax
3.5
9.1
41
119
N03AX09
ATC
lamotrigine; oral
2.3
9.1
86
389
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.6
9.0
25
45
RP120
NOMESCO Finland
NA
36.8
9.0
11
*
PA2BM
NOMESCO Finland
MRI examination of vessels in the head with 3 Tesla magnet
36.8
9.0
11
*
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.7
8.9
591
7307
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
8.9
125
670
N06AX11
ATC
mirtazapine; oral
1.4
8.8
616
4877
SPAT1053
SPAT
Memory test
1.5
8.8
282
1922
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
8.6
8.8
18
21
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
8.8
122
652
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
8.8
212
1348
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
7.2
8.7
20
28
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.2
8.7
83
379
SPAT1153
SPAT
Removal of sutures
1.3
8.7
648
5185
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.3
8.6
78
348
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.1
8.4
44
144
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
90.4
8.4
9
*
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
12.8
8.4
14
11
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.6
8.3
218
1412
4311A
ICD-9 Finland
Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS HYPERTONIA NON INDICAT]
+∞
8.3
8
*
AAC99
NOMESCO Finland
Other operation for aneurysm or other intracranial vascular lesion
+∞
8.3
8
*
4308X
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS ALIA DEFINITA]
+∞
8.3
8
*
43000
ICD-8 Finland
Subarachnoid haemorrhage, Post aneyrisma sacculare, cum hypertonia
+∞
8.3
8
*
2162
FHL
Wall reinforcement, big brain
+∞
8.3
8
*
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
+∞
8.3
8
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.9
8.3
32
82
C02AC05
ATC
moxonidine; oral
2.1
8.3
95
469
RS221
NOMESCO Finland
NA
3.3
8.3
39
118
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
10.8
8.3
15
14
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
10.8
8.3
15
14
ZY010
SPAT
NA
4.4
8.2
28
64
SPAT1101
SPAT
Orthostatic test
2.1
8.2
93
461
C08CA13
ATC
lercanidipine; oral
1.5
8.0
259
1770
127
Kela drug reimbursment
Transplant complication
3.6
7.9
34
96
N01
ICPC
Headache
1.8
7.9
144
844
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
4.1
7.9
29
72
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
7.9
133
761
S06.0
ICD-10 Finland
Concussion
1.7
7.9
174
1081
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.8
7.8
48
175
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
7.8
838
7047
AA1AA
NOMESCO Finland
Head X-ray examination
4.8
7.8
24
50
B01AA03
ATC
warfarin; systemic
1.4
7.7
338
2457
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
7.7
549
4345
PA2JT
NOMESCO Finland
Very extensive embolisation of arterio-venous malformation of the brain
45.1
7.7
9
*
3792A
ICD-9 Finland
Other disorders of eye, Disorders of vitreous body
45.1
7.7
9
*
I67.2
ICD-10 Finland
Cerebral atherosclerosis
18.4
7.6
11
6
C03AA03
ATC
hydrochlorothiazide; oral
1.6
7.6
189
1214
WZC00
SPAT
NA
2.1
7.5
78
373
EBA00
NOMESCO Finland
Extraction of tooth
1.3
7.4
585
4703
R50.9
ICD-10 Finland
Fever, unspecified
1.5
7.4
236
1606
OAB47
SPAT
NA
2.8
7.4
47
173
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.8
7.4
47
173
C09AA05
ATC
ramipril; oral
1.4
7.4
460
3563
TDA90
SPAT
NA
2.6
7.3
51
200
R01AD08
ATC
fluticasone; nasal
0.7
7.3
335
4391
I65.3
ICD-10 Finland
Occlusion and stenosis of multiple and bilateral precerebral arteries
+∞
7.3
7
*
G94.2
ICD-10 Finland
Hydrocephalus in other diseases classified elsewhere
+∞
7.3
7
*
2127
FHL
Ventriculostomy
+∞
7.3
7
*
AAK85
NOMESCO Finland
Replantation of previously excised part of skull cap
+∞
7.3
7
*
PA7CC
NOMESCO Finland
Very extensive angiography of arteries of neck and brain
+∞
7.3
7
*
N05BA01
ATC
diazepam; systemic, rectal
1.5
7.3
260
1817
ZXA05
NOMESCO Finland
Left side
1.3
7.2
503
3965
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
20.1
7.1
10
5
RK112
NOMESCO Finland
NA
12.1
7.1
12
10
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
7.1
133
788
SPAT1234
SPAT
Support of social functional capacity
1.9
7.1
96
510
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
10.0
7.0
13
13
7803A
ICD-9 Finland
General symptoms, Convulsions
4.3
7.0
24
56
C02EA02
ATC
NA
2.1
7.0
79
392
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
4.5
6.9
23
52
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.1
6.9
71
336
N03AE01
ATC
clonazepam; systemic
1.8
6.9
109
612
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
6.9
142
865
WX872
NOMESCO Finland
Intensive care
1.9
6.9
93
494
L28
ICPC
Limited function/disability (L)
1.5
6.8
278
1991
RS314
NOMESCO Finland
NA
11.0
6.8
12
11
SPAT1210
SPAT
Application of cast or individual aid
1.9
6.8
90
476
PA6AD
NOMESCO Finland
CT of neck arteries
4.5
6.8
22
49
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
4.5
6.8
22
49
N05AX08
ATC
risperidone; systemic
1.7
6.7
134
810
R53
ICD-10 Finland
Malaise and fatigue
1.4
6.7
344
2571
AAD15
NOMESCO Finland
Evacuation of traumatic intracerebral haematoma
22.6
6.7
9
*
G43.9
ICD-10 Finland
Migraine, unspecified
2.0
6.7
81
415
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.7
6.6
43
162
H34.1
ICD-10 Finland
Central retinal artery occlusion
6.4
6.6
16
25
WX892
NOMESCO Finland
Monitored bed care
1.7
6.6
120
704
WX100
NOMESCO Finland
Conjunctival surface anesthesia
0.6
6.6
82
1397
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
6.6
309
2277
C08CA05
ATC
nifedipine; systemic
1.7
6.5
120
708
RS313
NOMESCO Finland
NA
8.7
6.5
13
15
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
10.0
6.5
12
12
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
6.5
550
4452
EBA30
NOMESCO Finland
Excision of root of tooth
1.8
6.5
103
581
C09DA06
ATC
candesartan and diuretics; oral
1.6
6.5
149
939
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.9
6.4
85
448
Q28.0
ICD-10 Finland
Arteriovenous malformation of precerebral vessels
70.0
6.4
7
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.7
6.4
42
160
F05.9
ICD-10 Finland
Delirium, unspecified
3.0
6.4
34
115
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
6.4
217
1500
Z50.5
ICD-10 Finland
Speech therapy
3.8
6.4
25
67
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.0
6.3
72
361
H47.2
ICD-10 Finland
Optic atrophy
5.5
6.3
17
31
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.4
6.3
49
207
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
18.1
6.3
9
5
C09CA06
ATC
candesartan; oral
1.3
6.3
412
3211
PA2GT
NOMESCO Finland
Embolisation of arterio-venous malformation of the brain
+∞
6.3
6
*
2163
FHL
Proxies. Vascular ligation, big brain
+∞
6.3
6
*
4310A
ICD-9 Finland
Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS CUM HYPERTONIA]
+∞
6.3
6
*
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
+∞
6.3
6
*
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
+∞
6.3
6
*
AAC20
NOMESCO Finland
Anastomosis to intracranial vessel
+∞
6.3
6
*
2130
FHL
Ventricular atrial shunt
+∞
6.3
6
*
OAB43
SPAT
NA
0.6
6.2
105
1663
63701
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia
2.4
6.1
47
195
L15
ICPC
Knee symptom/complaint
0.7
6.1
234
3163
AXX01
SPAT
NA
3.2
6.1
29
91
CEC30
NOMESCO Finland
Resection of extraocular muscle
12.5
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
180
97
19.95
229.84
1.5
2.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
721
2237
4.15
205.00
7.9
7.8
kpa
13.7
12.3
7.22
697
2131
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
721
2238
4.14
204.86
7.9
7.8
kpa
5.1
5.1
0.53
698
2129
(3003396) Base excess in Arterial blood by calculation
717
2229
4.13
203.11
7.9
7.8
mmol/l
1.2
1.2
0.10
559
1747
(3020891) Body temperature
384
812
5.42
175.10
7.5
4.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
448
1245
4.18
144.22
11.7
7.3
mmol/l
24.9
24.7
0.76
435
1149
(3019060) Gas panel - Arterial blood
462
1315
4.10
143.91
7.5
5.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
563
1868
3.61
140.01
9.3
8.6
g/l
123.1
121.5
1.15
553
1787
(3016502) Oxygen saturation in Arterial blood
582
2000
3.50
136.80
9.1
8.2
%
96.3
95.6
1.76
571
1923
(3014576) Chloride [Moles/volume] in Serum or Plasma
627
2503
3.02
112.48
7.8
6.8
mmol/l
104.7
104.1
2.72
619
2445
(3018677) aPTT in Platelet poor plasma by Coagulation assay
631
2597
2.92
106.45
1.9
2.0
s
28.6
29.7
3.99
616
2511
(40761535) Cells panel - Urine sediment
469
1720
3.13
96.28
4.2
3.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
601
2673
2.65
85.16
8.6
6.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1007
5803
2.25
78.80
2.5
2.0
u/l
195.3
206.3
0.16
973
5394
(3011397) Hemoglobin [Presence] in Urine by Test strip
872
4735
2.30
78.77
4.9
3.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
811
4362
2.28
74.08
5.3
4.0
kg/l
1.0
1.0
0.02
46
618
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
423
1699
2.80
72.19
2.7
2.3
ug/l
5.3
6.8
0.91
386
1501
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
103
151
7.08
67.19
2.5
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
159
391
4.28
58.72
2.1
1.2
e6/l
54.3
35.9
0.48
139
303
(3029937) Albumin [Presence] in Urine by Test strip
894
5369
2.05
58.69
5.1
4.0
estimate
0.0
0.0
0.88
165
1809
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
159
392
4.27
58.52
2.1
1.3
e6/l
12411.9
986.7
2.14
141
321
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
279
1001
3.02
57.95
7.8
10.0
mmol/l
24.1
24.4
1.13
266
930
(3020779) Urea [Moles/volume] in Serum or Plasma
386
1699
2.51
53.73
7.0
7.5
mmol/l
7.5
10.0
13.12
363
1619
(3009542) Hematocrit [Volume Fraction] of Blood
1494
18400
0.52
50.69
18.6
15.0
%
39.5
39.7
0.44
1015
12917
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
59
62
9.73
50.49
3.4
2.7
umol/l
31.2
29.3
0.37
50
44
(4034850)
207
701
3.13
47.27
11.4
9.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
788
4932
1.88
42.94
3.9
3.7
%
95.2
91.5
3.92
755
4798
(3013826) Glucose [Moles/volume] in Serum or Plasma
1536
11804
1.80
41.77
7.6
4.6
mmol/l
6.7
6.7
0.18
1471
11056
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1270
9327
1.75
39.46
9.0
5.9
mmol/l
1.2
1.2
42.10
1206
8397
(3044290) Cell count panel - Cerebral spinal fluid
124
352
3.66
37.38
1.9
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
134
410
3.40
36.02
1.8
1.2
mmol/l
3.6
3.8
1.37
127
386
(3036489) Thrombin time
165
577
2.99
35.49
1.8
1.9
s
19.2
21.5
11.33
151
499
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
336
1670
2.17
34.37
2.6
2.6
ml/min/173m2
65.2
65.2
0.00
124
654
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
51
73
7.11
33.95
2.4
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
323
1605
2.17
32.99
9.0
8.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
445
2503
1.95
32.35
22.4
23.3
inr
1.6
1.3
1.21
26
343
(3015736) pH of Urine
1059
7702
1.66
31.65
4.6
3.4
—
5.8
—
0
8
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
43
58
7.53
30.15
2.3
2.1
umol/l
57.0
56.2
0.04
37
43
(3023410) Appearance of Cerebral spinal fluid
72
162
4.55
29.74
2.0
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1320
10264
1.62
29.34
9.0
6.7
mmol/l
1.2
1.2
36.18
1220
8643
(3014111) Lactate [Moles/volume] in Serum or Plasma
327
1713
2.05
28.87
7.8
7.1
mmol/l
1.4
1.3
0.19
314
1654
(3044640) Blood type and Crossmatch panel - Blood
895
6350
1.64
28.72
2.4
2.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
471
7306
0.56
27.45
2.7
2.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1043
7761
1.60
27.10
3.9
3.4
ng/l
34.6
49.2
1.09
799
5333
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
711
4855
1.65
26.00
2.4
2.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1025
7668
1.58
25.58
4.9
3.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
430
2568
1.82
25.41
7.2
5.8
mmol/l
1.0
1.0
2.22
407
2369
(3016018) Differential panel - Cerebral spinal fluid
69
170
4.15
25.39
2.1
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
502
3240
1.69
22.31
2.8
3.4
mmol/l
0.8
0.8
1.41
471
3011
(3003181) Sodium [Moles/volume] in Urine
97
348
2.86
19.93
1.6
1.4
mmol/l
89.4
61.3
5.55
82
280
(3035350) Ketones [Presence] in Urine by Test strip
1229
9938
1.47
19.32
4.8
3.6
estimate
0.0
0.0
0.00
176
1817
(3024354) Oxygen [Partial pressure] in Venous blood
265
1476
1.89
19.27
3.6
2.9
kpa
4.7
4.5
0.89
258
1431
(3023368) Bacteria identified in Blood by Culture
742
5438
1.52
18.86
4.0
4.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1237
10093
1.45
18.08
4.8
3.7
estimate
0.0
0.0
1.08
173
1803
(3021447) Carbon dioxide [Partial pressure] in Venous blood
300
1784
1.78
17.59
4.5
3.6
kpa
6.0
5.9
1.06
293
1732
(3021601) Nitrite [Presence] in Urine by Test strip
1218
9993
1.43
16.79
5.6
4.9
estimate
0.0
0.0
0.50
171
1850
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
129
2636
0.46
16.75
4.8
4.5
%
32.0
32.5
0.19
92
1716
(3002032) Base excess in Venous blood by calculation
294
1768
1.75
16.54
4.6
3.6
mmol/l
2.2
2.0
0.51
255
1458
(3032080) INR in Blood by Coagulation assay
1011
8041
1.44
16.39
7.7
8.8
inr
1.2
1.2
0.63
249
2292
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
30
53
5.72
16.33
1.2
1.1
%
8.0
9.4
—
21
5
(3004119) Hemoglobin [Mass/volume] in Venous blood
221
1228
1.88
16.13
3.6
3.1
g/l
127.1
128.5
0.41
221
1196
(3002385) Erythrocyte distribution width [Ratio]
1481
16834
0.70
16.02
19.2
17.0
%
13.9
13.7
2.16
1456
16441
(3013512) EKG study
434
6184
0.64
15.71
4.0
3.7
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
43
107
4.07
15.69
2.7
2.6
umol/l
16.8
43.8
—
5
5
(3003338) MCHC [Mass/volume]
1886
17033
1.46
13.69
23.3
18.0
g/l
331.9
332.0
0.26
1869
16907
(3024561) Albumin [Mass/volume] in Serum or Plasma
1081
8887
1.39
13.68
4.9
4.8
g/l
34.8
35.5
3.96
1027
8244
(3009466) Valproate [Moles/volume] in Serum or Plasma
67
247
2.76
13.18
3.3
5.8
umol/l
353.0
369.8
0.36
56
220
(3026008) Bacteria identified in Urine by Culture
779
6102
1.41
12.96
3.5
3.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
726
9110
0.71
12.78
7.1
6.0
%
0.7
0.7
0.02
688
8450
(3006504) Eosinophils/100 leukocytes in Blood
752
9362
0.72
12.54
6.8
6.0
%
2.9
2.9
0.06
709
8675
(3002030) Lymphocytes/100 leukocytes in Blood
778
9631
0.72
12.53
6.8
6.1
%
26.9
28.0
2.22
732
8912
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
335
2234
1.58
12.49
1.8
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
334
2233
1.57
12.31
1.8
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
517
6833
0.69
12.11
6.3
5.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
191
1108
1.78
12.10
1.6
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
760
9407
0.72
12.07
7.0
6.3
%
8.7
8.7
0.08
721
8754
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1124
9438
1.35
11.85
4.4
3.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
772
9495
0.73
11.63
6.8
5.9
%
57.9
57.1
1.20
732
8822
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
328
2224
1.55
11.32
1.8
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
685
8501
0.73
10.63
2.0
2.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1823
19616
0.73
10.28
14.2
12.9
ml/min/173m2
80.4
79.1
1.85
1594
16132
(3041096) Erythrocytes [Presence] in Urine by Automated
393
5320
0.69
10.16
3.8
3.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
52
4.46
9.55
1.4
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
38
123
3.12
9.49
1.3
1.1
mmol/l
27.5
34.0
1.36
32
107
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
508
3889
1.39
9.19
2.5
3.0
mmol/l
2.4
2.5
0.81
444
3421
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
110
593
1.90
8.87
2.8
3.1
u/ml
0.4
0.3
0.21
60
326
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
445
5735
0.73
8.34
1.7
1.7
mmol/l
1.5
1.4
1.05
393
4774
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
92
1679
0.53
8.33
1.9
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1920
20361
0.74
8.30
4.5
4.5
mmol/l
1.4
1.5
4.93
1806
18668
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
423
3195
1.39
8.22
2.0
1.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
22
55
4.03
8.07
5.8
5.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1167
13165
0.78
8.03
3.2
3.1
u/l
56.3
50.3
1.27
1091
12157
(3031040) Bacteria [#/volume] in Urine by Automated count
1472
13242
1.28
7.89
4.9
4.4
e6/l
2052.7
2117.9
—
7
188
(3019225) pH of Specimen
131
2118
0.60
7.64
7.2
4.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
99
544
1.85
7.57
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1944
20509
0.75
7.33
4.6
4.5
mmol/l
4.5
4.8
18.22
1836
18915
(3023183) Ammonium ion [Moles/volume] in Plasma
76
388
1.99
7.24
1.9
3.0
umol/l
34.1
38.3
0.60
66
327
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
439
3403
1.35
7.19
2.6
2.7
e6/l
1.6
1.1
0.52
290
1934
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
96
3.04
7.04
1.2
1.1
—
—
—
0
0
(4035726)
119
1919
0.60
6.87
1.4
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
733
6138
1.28
6.80
5.0
4.0
ph
7.4
7.4
1.08
98
1180
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
103
606
1.73
6.32
1.5
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
1618
14901
1.25
6.30
3.9
3.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
104
2.81
6.16
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
55
1070
0.50
6.14
3.3
3.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
126
797
1.61
5.90
2.2
2.0
ug/l
1.9
2.0
0.01
111
712
(3019309) Folate [Moles/volume] in Red Blood Cells
463
3723
1.30
5.78
1.8
1.7
nmol/l
1471.5
1185.5
8.17
398
2770
(3039000) Anion gap in Blood
79
442
1.81
5.78
11.1
9.3
mmol/l
11.0
11.4
0.28
71
387
(3018572) Chloride [Moles/volume] in Blood
79
442
1.81
5.78
11.1
9.3
mmol/l
106.8
105.2
2.33
71
387
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
126
815
1.58
5.40
7.9
6.4
%
1.8
1.6
1.11
117
757
(3001019) Free T4 and TSH panel - Serum or Plasma
52
985
0.52
5.38
2.2
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
618
5196
1.25
5.33
6.4
6.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
155
1059
1.49
5.19
12.2
11.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2007
20912
0.78
5.14
5.3
5.0
mmol/l
2.6
2.8
17.65
1888
19174
(40761536) Microorganisms panel - Urine sediment
112
1708
0.64
5.11
5.1
3.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
285
3673
0.75
5.06
2.4
3.0
ug/l
0.8
0.7
0.38
190
2415
(3024932) HLA-DR beta [Type]
19
61
3.13
4.91
1.0
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
52
269
1.95
4.88
3.6
7.2
mg/l
10.5
12.1
1.52
47
249
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
64
1103
0.57
4.83
1.5
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
19
62
3.08
4.79
1.0
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
122
810
1.53
4.70
7.9
6.4
%
0.9
0.9
0.23
114
752
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
42
204
2.08
4.70
1.0
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
32
139
2.32
4.68
1.5
1.4
promille
1.6
1.1
0.70
21
105
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
692
5966
1.22
4.64
2.6
2.9
ng/l
1349.6
1319.1
0.07
616
5081
(3014148) Varicella zoster virus Ab [Titer] in Serum
38
181
2.12
4.48
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
207
2744
0.73
4.43
1.3
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
24
94
2.57
4.38
1.6
2.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
642
5534
1.22
4.26
3.4
3.0
e6/l
0.4
0.4
0.09
514
4155
(1761482) Bacteria [#/volume] in Urine by Culture
22
519
0.42
4.26
4.8
4.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2129
21947
0.78
4.24
11.1
10.5
u/l
25.6
26.2
0.71
2079
21152
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
22
84
2.63
4.23
2.1
1.1
%
47.1
70.0
—
10
9
(3051387) C reactive protein [Mass/volume] in Capillary blood
18
459
0.39
4.19
3.2
3.8
mg/l
46.6
26.6
—
9
290
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
38
187
2.05
4.14
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
38
187
2.05
4.14
1.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
38
187
2.05
4.14
1.3
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
86
1319
0.64
4.07
3.0
3.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2212
22675
0.75
4.06
25.8
20.7
g/l
133.4
135.3
7.15
2191
22336
(3026361) Erythrocytes [#/volume] in Blood
2212
22671
0.76
4.00
25.8
20.6
e12/l
4.4
4.5
14.03
2173
21987
(3035941) MCH [Entitic mass]
2212
22669
0.76
3.97
25.6
20.5
pg
30.6
30.4
4.86
2191
22325
(3024731) MCV [Entitic volume]
2212
22668
0.76
3.96
25.6
20.5
fl
91.9
91.3
7.80
2192
22326
(3010813) Leukocytes [#/volume] in Blood
2213
22673
0.76
3.91
25.7
20.6
e9/l
7.0
6.6
9.18
2175
21985
(3007461) Platelets [#/volume] in Blood
2212
22663
0.76
3.89
25.7
20.6
e9/l
254.7
251.1
1.76
2177
22052
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1886
19662
0.82
3.86
4.2
4.0
mmol/l
1.4
1.3
3.29
1757
17884
(4024509)
5
205
0.24
3.82
2.0
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
89
581
1.55
3.76
1.2
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
494
4197
1.22
3.75
3.0
2.5
e6/l
5.5
5.7
0.10
441
3668
(36304419) Bacteria [Presence] in Urine
619
5384
1.20
3.67
3.4
3.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
89
585
1.54
3.66
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
88
577
1.54
3.66
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
42
226
1.87
3.60
1.3
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
73
462
1.60
3.54
1.6
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
15
52
2.90
3.46
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
15
53
2.84
3.35
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
42
232
1.82
3.34
1.4
1.2
u/ml
3.5
4.0
0.14
19
90
(3051593) INR in Capillary blood by Coagulation assay
14
48
2.93
3.30
5.4
17.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
52
308
1.70
3.28
1.6
1.4
u/ml
138.5
123.0
—
10
62
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
575
6549
0.84
3.27
3.3
3.2
u/l
35.8
36.6
0.06
546
6204
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1957
20252
0.83
3.18
4.8
4.6
mmol/l
6.0
6.0
0.33
1842
18406
(4281824)
9
248
0.36
3.17
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
119
1626
0.72
3.12
1.3
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
793
7138
1.16
3.05
2.8
3.4
mmol/l
2.4
2.4
0.83
701
6221
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
730
6530
1.17
3.04
2.8
2.5
u/l
56.2
58.6
0.83
678
6005
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
174
2237
0.76
3.04
3.6
4.1
ug/l
27.2
19.8
0.23
159
1795
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1804
18775
0.85
3.01
4.7
4.8
mu/l
2.0
2.1
0.65
1711
17076
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
42
241
1.76
2.98
1.3
1.2
u/ml
4.7
1.7
0.59
16
80
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
122
893
1.39
2.94
5.8
3.9
mmol/l
24.4
24.2
0.36
102
803
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
35
3.15
2.93
1.1
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
227
1819
1.27
2.92
2.3
2.2
nmol/l
378.5
369.2
0.35
211
1656
(3042936) Bacteria identified in Isolate by Culture
339
2843
1.22
2.91
1.9
2.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
18
76
2.38
2.89
1.4
2.9
umol/l
104.3
195.4
—
7
48
(3006653) Thiamine [Moles/volume] in Blood
24
115
2.10
2.88
1.2
1.3
nmol/l
133.1
138.7
0.22
24
115
(3020630) Protein [Mass/volume] in Serum or Plasma
210
1673
1.28
2.84
2.0
2.9
g/l
65.9
66.6
0.77
190
1524
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
55
346
1.60
2.80
1.7
1.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
29
154
1.89
2.66
1.1
1.0
ng/l
548.5
747.9
1.60
13
96
(3047181) Lactate [Moles/volume] in Blood
87
613
1.43
2.63
11.3
7.8
mmol/l
1.2
1.3
0.59
77
525
(3039443) Prostate specific Ag panel - Serum or Plasma
20
401
0.49
2.62
1.2
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
31
543
0.57
2.62
1.2
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
557
6260
0.86
2.61
4.3
4.9
ug/l
2.0
2.7
2.57
508
5619
(3007164) IgA [Mass/volume] in Serum or Plasma
309
3647
0.83
2.57
1.4
1.5
g/l
2.6
2.5
0.71
195
2183
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
29
156
1.87
2.57
1.1
1.0
ng/l
390.4
331.0
0.29
14
101
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
29
156
1.87
2.57
1.1
1.0
ng/l
51.4
48.3
0.10
14
98
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
18
81
2.23
2.54
1.1
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
21
406
0.51
2.48
3.8
3.5
%
59.3
57.3
0.33
21
406
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
76
530
1.45
2.45
2.1
1.6
g/l
0.2
0.2
1.55
71
499
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
295
3480
0.83
2.44
1.3
1.2
u/ml
15.4
12.4
0.12
147
1341
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1100
11753
0.88
2.40
2.6
2.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
120
911
1.33
2.36
1.4
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1864
19255
0.87
2.34
5.7
5.8
mmol/mol
39.9
39.9
0.04
1775
17748
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
16
71
2.26
2.34
1.1
1.1
miu/ml
1286.0
1682.7
0.58
16
71
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
176
1410
1.27
2.32
1.8
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
790
8603
0.88
2.32
2.3
2.2
nmol/l
78.3
78.7
0.16
725
7696
(3015171) Extractable nuclear Ab [Units/volume] in Serum
103
767
1.36
2.30
1.4
1.2
u/ml
1.2
0.8
0.17
28
66
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
11
261
0.42
2.30
1.1
1.0
u/ml
1.2
2.8
—
5
108
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
193
1567
1.25
2.27
5.5
3.6
ng/l
95.0
88.8
0.37
180
1364
(3037467) Urinalysis macro (dipstick) panel - Urine
1321
13926
0.89
2.23
4.7
4.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
9
5.56
2.21
1.2
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
24
3.34
2.18
5.4
4.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
77
552
1.41
2.17
2.0
1.6
g/l
1.1
1.2
0.78
72
524
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
21
108
1.95
2.15
1.4
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
26
144
1.81
2.14
1.3
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1155
10851
1.12
2.14
5.2
6.2
umol/l
10.1
11.3
3.09
1104
10289
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
25
137
1.83
2.13
1.2
1.2
titre
117.5
133.3
—
8
27
(36660697) Celiac disease serology panel - Serum
115
1484
0.76
2.13
1.2
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
25
3.21
2.09
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
51
341
1.51
2.07
1.6
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
30
494
0.60
2.07
1.9
2.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
22
117
1.89
2.06
3.4
3.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
117
1.89
2.06
1.2
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
20
103
1.95
2.05
1.4
2.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
15
69
2.18
2.04
2.1
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
47
310
1.53
2.03
1.5
1.2
u/ml
273.4
272.0
0.01
31
191
(3038026) Centromere Ab [Units/volume] in Serum
7
175
0.40
2.03
1.0
1.1
—
94.9
—
0
6
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
6
161
0.37
2.01
1.0
1.1
—
4.6
—
0
9
(3028707) Methadone [Presence] in Urine by Screen method
28
163
1.73
1.98
1.9
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
34
209
1.64
1.98
1.4
1.6
—
—
—
0
0
(4010399)
182
1495
1.23
1.96
1.4
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
21
3.34
1.96
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
36
226
1.60
1.93
2.0
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
179
2163
0.81
1.92
4.1
3.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
49
331
1.49
1.92
1.4
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
493
4424
1.14
1.90
4.0
4.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
705
6472
1.13
1.90
3.1
3.1
mmol/l
7.4
7.4
0.07
629
5417
(3000764) Benzodiazepines [Presence] in Urine
53
365
1.46
1.89
1.6
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
52
0.00
1.88
0.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
53
754
0.70
1.87
1.6
1.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
28
2.86
1.86
1.1
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
28
2.86
1.86
1.1
1.1
%
96.8
97.7
—
8
28
(3017732) Neutrophils [#/volume] in Blood
113
1432
0.78
1.85
4.1
3.3
e9/l
4.0
4.1
0.06
86
1103
(3008295) Osmolality of Serum or Plasma
34
213
1.60
1.85
1.8
1.3
mosm/kgh2o
276.9
277.1
0.02
27
162
(44806071)
6
17
3.54
1.83
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
53
368
1.45
1.82
1.6
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
39
254
1.54
1.81
2.0
2.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
15
288
0.52
1.81
1.1
1.1
—
12.3
—
0
15
(3027944) Amphetamines [Presence] in Urine
52
361
1.45
1.79
1.5
1.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
7
167
0.42
1.78
1.0
1.1
—
44.8
—
0
6
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
168
0.42
1.78
1.0
1.1
—
60.3
—
0
12
(3034426) Prothrombin time (PT)
11
47
2.35
1.77
1.3
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
73
975
0.74
1.77
1.9
2.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
493
4449
1.14
1.75
1.6
1.7
pmol/l
27828514.9
41518052.1
0.27
442
3690
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
319
3630
0.86
1.75
1.3
1.3
iu/ml
36.6
35.3
0.07
96
1167
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
110
1.82
1.73
1.2
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
78
586
1.34
1.72
1.5
1.7
—
—
—
0
0
(4306422)
37
242
1.54
1.70
1.2
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
27
164
1.65
1.68
1.1
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
55
2.19
1.67
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
52
367
1.43
1.66
1.6
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
69
2.03
1.64
3.9
2.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
131
1605
0.81
1.64
3.5
4.0
%
0.7
0.6
0.05
24
351
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
49
2.25
1.63
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
56
2.15
1.61
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
135
1101
1.24
1.60
1.3
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
13
63
2.07
1.59
3.9
7.7
mmol/l
25.3
24.9
0.13
13
58
(3052851) Hemolysis interference index of Serum or Plasma
77
585
1.33
1.59
3.7
3.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
33
214
1.55
1.59
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
106
1325
0.79
1.59
2.7
2.3
nmol/l
13.5
13.1
0.15
90
1165
(3004616) Nuclear Ab [Presence] in Serum
14
261
0.53
1.57
1.1
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
37
248
1.50
1.55
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
64
2.04
1.54
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
115
1417
0.80
1.53
1.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
42
0.00
1.52
0.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
676
6262
1.11
1.52
3.1
3.2
mg/l
218.2
332.2
0.42
471
3839
(3021440) Promyelocytes/100 leukocytes in Blood
138
1666
0.82
1.51
3.5
4.2
%
0.2
0.1
0.10
32
439
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
27
2.60
1.51
1.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
7
27
2.60
1.51
1.0
1.1
—
80.5
—
0
8
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
54
734
0.73
1.51
1.4
1.7
mg/l
5.9
3.7
0.38
38
521
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
11
51
2.16
1.50
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
11
51
2.16
1.50
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
86
1.87
1.50
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
55
401
1.38
1.49
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
55
401
1.38
1.49
1.2
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
40
275
1.46
1.49
1.6
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
5
129
0.39
1.48
1.0
1.8
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
7
28
2.50
1.45
1.0
1.1
—
84.6
—
0
9
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
28
2.50
1.45
1.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
66
1.97
1.43
1.0
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
754
7048
1.10
1.41
4.3
3.6
e6/l
81.6
107.7
0.68
562
4974
(3025159) Blasts/100 leukocytes in Blood
131
1576
0.82
1.40
3.6
4.3
%
0.0
0.5
0.96
24
372
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
137
0.44
1.40
1.8
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
537
4937
1.11
1.39
2.4
2.2
mg/l
3.4
3.0
2.96
486
4174
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
146
1735
0.83
1.38
5.0
4.0
mmol/l
1.2
1.2
0.42
133
1499
(44790049)
36
247
1.46
1.37
1.4
1.5
—
—
—
0
0
(44790047)
36
247
1.46
1.37
1.4
1.5
—
—
—
0
0
(44790048)
36
247
1.46
1.37
1.4
1.5
—
—
—
0
0
(44806118)
36
247
1.46
1.37
1.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
216
1873
1.17
1.37
1.9
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
26
166
1.57
1.37
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
274
3091
0.87
1.36
1.4
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
24
371
0.64
1.35
1.3
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
136
1135
1.21
1.34
1.9
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
16
90
1.78
1.33
2.2
2.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
24
152
1.58
1.31
1.3
1.5
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
14
245
0.57
1.31
3.1
3.4
nmol/l
7.7
26.9
0.40
14
240
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
20
121
1.66
1.30
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
232
0.56
1.30
1.3
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
36
507
0.71
1.28
1.2
1.6
pmol/l
87.4
241.9
2.95
36
496
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
114
1.67
1.28
1.5
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
378
4158
0.89
1.26
1.2
1.2
u/ml
1.1
1.6
1.20
132
1113
(3021788) Differential panel - Synovial fluid
25
376
0.66
1.26
1.4
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1479
15279
0.92
1.26
3.9
4.1
mm/h
14.1
12.5
3.42
1389
14061
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
251
2219
1.15
1.25
2.0
1.8
%
1.8
1.5
3.71
230
1941
(3017181) Myelocytes/100 leukocytes in Blood
149
1748
0.84
1.24
3.4
4.2
%
1.0
0.9
0.10
39
472
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
123
1.63
1.24
1.1
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
189
1639
1.17
1.22
2.2
2.6
e9/l
77.3
70.4
1.35
146
1245
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
8
37
2.17
1.21
1.0
1.2
—
6.5
—
0
7
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
26
172
1.52
1.20
2.4
2.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
38
2.11
1.18
1.0
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
6
127
0.47
1.16
2.3
2.1
ug/l
2.0
2.1
—
6
115
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
50
2.00
1.16
5.9
9.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
36
257
1.41
1.15
2.0
2.0
u/l
10210.6
2401.0
0.48
11
92
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
223
0.58
1.15
1.7
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
72
1.81
1.15
2.3
2.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
153
0.52
1.14
1.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
36
0.00
1.14
0.0
2.3
—
4.8
—
0
15
(40768800) Prostate Pathology biopsy report
29
413
0.70
1.13
1.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
700
6587
1.09
1.11
3.7
3.9
mg/mmol
9.3
7.9
0.40
482
4060
(21494890) Protein electrophoresis panel - 24 hour Urine
31
217
1.43
1.11
1.5
2.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
10
51
1.96
1.11
1.1
1.1
%
140.1
107.8
—
10
44
(3038515) Glucose [Moles/volume] in Venous blood
30
422
0.71
1.09
2.9
3.1
mmol/l
7.3
7.5
0.15
30
410
(4094501)
47
616
0.76
1.09
1.1
1.1
—
—
—
0
0
(4268621)
24
160
1.50
1.09
2.6
2.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
18
112
1.61
1.08
1.6
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
55
426
1.30
1.07
4.1
3.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
270
2426
1.13
1.07
1.4
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
51
391
1.31
1.07
1.4
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
29
408
0.71
1.06
3.7
3.6
u/ml
17.7
34.4
2.42
29
399
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
159
1378
1.16
1.06
2.2
2.4
au/ml
28.9
22.3
—
6
67
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
33
236
1.40
1.06
2.2
1.8
ug/l
16.0
25.4
0.97
33
231
(4146454)
15
242
0.62
1.06
2.3
2.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
21
314
0.67
1.06
2.9
3.5
%
1.6
1.5
0.03
15
244
(3019550) Sodium [Moles/volume] in Serum or Plasma
2172
21419
1.12
1.06
22.1
15.9
mmol/l
139.4
139.7
5.19
2147
20879
(3010421) pH of Blood
68
543
1.26
1.05
4.7
4.1
ph
7.4
7.4
0.24
39
448
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
121
0.49
1.05
1.8
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
216
0.60
1.04
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
72
580
1.25
1.04
1.4
1.6
iu/ml
0.0
11.7
0.50
28
104
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49
376
1.31
1.03
1.3
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
470
4362
1.10
1.02
1.8
1.7
mg/l
1.2
1.2
0.12
378
3349
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
37
273
1.36
1.01
1.2
1.3
—
—
—
0
0
(4198724)
9
48
1.88
1.00
1.6
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
44
335
1.32
0.98
1.5
1.4
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
9
49
1.84
0.98
1.1
2.7
%
134.3
175.8
—
9
43
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
38
283
1.35
0.98
1.5
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
135
0.52
0.98
2.9
6.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
161
0.56
0.97
1.7
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
258
1.36
0.97
1.3
1.3
nmol/l
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
783
8226
0.93
0.95
3.0
2.7
ug/l
137.3
136.2
0.05
736
7556
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
198
0.60
0.95
4.7
4.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
246
0.65
0.94
2.4
2.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
36
268
1.35
0.94
1.2
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
27
2.23
0.93
1.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
120
0.50
0.93
1.8
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
38
499
0.76
0.93
1.3
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
55
1.82
0.92
5.9
8.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
81
672
1.21
0.92
2.6
2.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
20
134
1.50
0.91
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
20
134
1.50
0.91
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
20
134
1.50
0.91
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
176
1983
0.88
0.91
1.4
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
49
385
1.28
0.89
1.8
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
297
1.32
0.89
1.3
1.5
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
29
2.07
0.89
2.3
2.0
mmol/l
1.2
1.2
—
6
29
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
266
0.67
0.89
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
266
0.67
0.89
1.2
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
74
892
0.82
0.89
1.2
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
37
484
0.76
0.89
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
103
0.48
0.89
1.4
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
56
1.79
0.87
1.1
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
864
9021
0.93
0.87
9.3
9.5
e9/l
0.0
0.0
0.06
725
7354
(3024891) Influenza virus A+B Ag [Presence] in Specimen
61
494
1.24
0.87
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
87
1.61
0.87
1.4
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
14
217
0.64
0.87
1.1
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
96
1.57
0.84
1.1
1.1
ratio
1.1
1.0
—
5
37
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
20
137
1.46
0.84
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
20
137
1.46
0.84
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
20
137
1.46
0.84
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
57
1.76
0.83
1.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
142
1248
1.15
0.83
1.2
1.3
au/ml
62.9
45.6
—
8
52
(3004588) Protein electrophoresis panel - Serum or Plasma
160
1418
1.14
0.83
2.0
2.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
138
0.58
0.83
1.3
1.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
57
462
1.24
0.82
1.3
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
32
240
1.34
0.82
1.1
1.4
pmol/l
236.1
293.4
0.99
24
192
(3038177) Helicobacter pylori Ab [Presence] in Serum
22
307
0.71
0.82
1.2
1.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
13
81
1.61
0.81
1.6
1.9
ug/l
23.7
118.4
0.46
13
70
(3005322) IgE [Units/volume] in Serum or Plasma
107
1236
0.86
0.81
1.3
1.3
u/ml
185.7
197.0
0.06
101
1139
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
89
1.58
0.81
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
89
1.58
0.81
1.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
43
338
1.28
0.80
1.3
1.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2171
21942
0.91
0.80
20.4
16.3
umol/l
77.2
76.7
0.19
2171
21932
(1002224) Polysomnography panel
68
815
0.83
0.79
1.1
1.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.5
—
438895.8
—
0
18
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
273
2971
0.91
0.79
1.3
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
26
0.00
0.78
0.0
2.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
14
90
1.56
0.78
1.7
2.3
%
100.4
97.9
0.08
14
83
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
21
148
1.42
0.77
1.3
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
7
124
0.56
0.77
2.0
1.9
—
11.1
—
0
6
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
198
0.65
0.76
1.4
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
11
174
0.63
0.76
2.1
2.0
e9/l
1.4
1.1
—
6
110
(3023511) Choriogonadotropin [Units/volume] in Urine
19
132
1.44
0.76
1.2
1.3
—
—
—
0
0
(44813793)
19
132
1.44
0.76
1.2
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
14
91
1.54
0.75
1.6
2.5
u/ml
497.1
1413.4
2.21
14
91
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
26
192
1.36
0.75
3.5
2.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
56
679
0.82
0.75
1.6
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
54
1.67
0.74
1.4
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
65
776
0.83
0.74
5.7
3.6
mmol/l
25.3
25.0
0.37
56
725
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
17
243
0.70
0.74
1.3
1.2
mmol/l
7.9
7.6
0.13
17
175
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
126
1426
0.88
0.73
1.3
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
39
1.80
0.72
3.0
8.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
6
109
0.55
0.72
8.2
12.4
nmol/l
680.8
850.2
—
6
103
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
26
344
0.75
0.71
1.5
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
112
1274
0.87
0.71
1.1
1.2
iu/ml
56.8
155.7
4.13
50
474
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
40
1.75
0.71
1.0
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
64
760
0.84
0.70
2.6
3.5
u/ml
482.9
3003.7
0.89
56
642
(3013115) Eosinophils [#/volume] in Blood
1009
10424
0.95
0.70
6.2
5.9
e9/l
0.2
0.2
0.31
896
9084
(3022313) Gas panel - Capillary blood
77
899
0.85
0.69
5.3
3.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2171
21487
1.09
0.69
21.2
16.0
mmol/l
4.0
4.0
0.23
2139
20915
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
27
1.85
0.68
1.0
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
96
1100
0.87
0.68
2.2
2.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
15
102
1.47
0.67
1.3
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
47
384
1.23
0.66
8.8
5.4
iu/ml
210.3
322.1
0.40
12
56
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
294
1.26
0.66
3.7
2.7
u/ml
—
2235.3
—
0
23
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
49
592
0.82
0.65
1.3
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
28
215
1.31
0.65
1.5
1.4
u/l
30.6
33.5
0.19
22
177
(1617658) Protocol used for examination of sentinel lymph nodes
14
201
0.69
0.64
1.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
37
296
1.25
0.63
1.4
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
332
3108
1.08
0.63
3.2
2.5
umol/l
13.2
13.1
0.07
308
2867
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
303
0.76
0.63
1.0
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
33
414
0.79
0.63
1.5
1.2
u/ml
1.1
4.4
—
6
32
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
16
223
0.72
0.62
1.2
1.2
u/l
41.3
57.6
—
8
161
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
79
1.52
0.62
1.1
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1543
15729
0.95
0.62
4.0
4.1
pmol/l
15.0
14.9
1.09
1449
14258
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
45
371
1.22
0.60
1.5
1.3
u/l
9.8
11.5
0.40
37
304
(1175426) CD3 cells/100 lymphocytes in Blood
9
141
0.64
0.60
1.4
1.9
%
73.3
73.1
—
9
131
(3001729) Color of Synovial fluid
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
22
0.00
0.59
0.0
4.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
154
1692
0.90
0.58
2.7
2.9
ng/l
232.4
188.7
0.53
139
1530
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
35
431
0.81
0.58
1.5
1.7
nmol/l
0.8
0.8
0.05
27
354
(40760888) Immunoglobulin light chains.free panel - Serum
41
496
0.82
0.57
2.8
3.9
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
149
0.67
0.56
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
96
850
1.13
0.56
1.5
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
28
221
1.27
0.55
5.0
5.7
mmol/l
6.8
7.4
0.51
20
186
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
96
852
1.13
0.55
1.6
1.9
u/l
38.4
39.5
0.16
82
753
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
481
5034
0.94
0.53
4.1
4.2
%
21.0
21.4
0.24
244
2434
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
25
316
0.79
0.53
1.3
1.1
iu/ml
69.7
84.8
—
6
65
(3049717) Cytology report of Urine Cyto stain
87
770
1.13
0.52
3.0
2.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
219
2037
1.08
0.52
1.9
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
60
693
0.86
0.51
3.5
3.2
g/l
0.3
0.3
0.01
26
273
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
70
799
0.87
0.51
2.5
1.8
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
11
75
1.47
0.50
1.0
1.0
%
106.7
95.5
0.54
11
55
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
41
1.46
0.50
2.8
2.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
41
1.46
0.50
1.2
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
255
2391
1.07
0.49
2.0
1.6
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
7
108
0.65
0.48
2.7
2.1
—
199.2
—
0
24
(3026493) Urate [Moles/volume] in Serum or Plasma
528
5496
0.95
0.48
2.8
2.6
umol/l
2802.0
5304.7
0.97
468
4763
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
16
119
1.35
0.48
1.3
1.5
u/l
10.9
13.6
1.40
16
114
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2058
20388
1.06
0.47
18.0
13.8
mg/l
27.4
23.8
4.70
1778
16116
(3027945) Reticulocytes/100 erythrocytes in Blood
231
2164
1.07
0.47
2.3
2.5
%
2.0
1.8
1.51
210
1917
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
107
1180
0.90
0.46
4.7
3.4
mmol/l
1.9
2.0
0.08
74
891
(3035320) C reactive protein [Mass/volume] in Body fluid
10
142
0.70
0.46
1.8
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
507
5272
0.95
0.45
1.3
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
64
725
0.88
0.44
2.5
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
152
0.72
0.44
1.4
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
51
1.37
0.44
1.0
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
110
1206
0.91
0.43
1.7
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
31
1.61
0.43
1.2
2.1
umol/l
19.6
19.5
—
5
31
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
93
0.64
0.42
1.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
32
1.56
0.42
1.0
1.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
10
70
1.43
0.41
1.3
2.4
%
130.0
159.7
—
10
65
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
45
520
0.86
0.41
1.4
1.2
u/ml
2.7
8.7
—
5
54
(3029634) Reagin Ab [Titer] in Serum by VDRL
29
240
1.21
0.41
2.1
2.0
—
3.3
—
0
6
(3000285) Sodium [Moles/volume] in Blood
5
33
1.52
0.41
1.4
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
5.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
46
530
0.87
0.41
1.4
1.2
u/ml
7.3
8.3
—
9
88
(3008898) HLA-B27 [Presence]
55
625
0.88
0.41
1.1
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
17
0.00
0.40
0.0
4.1
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
0.7
—
0
11
(3037522) Nuclear Ab [Titer] in Serum
254
2682
0.94
0.40
1.4
1.3
titre
499.6
494.1
0.02
57
555
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
103
0.68
0.39
1.0
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
176
1880
0.93
0.39
2.9
2.4
u/l
32.8
40.0
1.37
155
1616
(3004775) Volume in Urine collected for unspecified duration
13
171
0.76
0.39
3.4
2.1
ml
566.7
654.7
0.65
13
110
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
171
0.76
0.39
1.2
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
2.0
1.3
ng/l
80.4
100.8
—
5
35
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
240.7
—
0
8
(3025549) Creatine [Moles/time] in 24 hour Urine
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
19
0.00
0.39
0.0
1.7
—
0.1
—
0
13
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
115
1248
0.92
0.38
2.9
3.4
pmol/l
4.5
4.5
0.41
101
1099
(3019977) pH of Arterial blood
13
98
1.33
0.37
1.7
3.0
ph
7.4
7.4
—
6
35
(3042111) Morphology [Interpretation] in Bone marrow Narrative
30
354
0.85
0.37
1.3
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
221
2335
0.94
0.36
1.3
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
47
534
0.88
0.36
1.6
1.7
e6/l
18171.9
13080.9
0.37
40
385
(3002582) Erythrocytes [#/volume] in Urine
620
6021
1.04
0.36
3.8
3.1
e6/l
44.1
66.6
1.10
492
4615
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
49
555
0.88
0.36
1.1
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
56
498
1.13
0.35
2.3
2.3
ug/min
119.9
112.2
0.04
35
293
(3002523) Influenza virus A Ag [Presence] in Specimen
23
277
0.83
0.35
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
57
508
1.12
0.35
1.4
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
64
575
1.12
0.35
1.4
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
56
499
1.13
0.35
1.4
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
37
320
1.16
0.34
1.1
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
59
658
0.89
0.34
2.9
3.8
mg/l
46.6
72.8
0.55
50
529
(3003740) Influenza virus B Ag [Presence] in Specimen
23
276
0.83
0.34
1.0
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
59
657
0.90
0.34
2.9
3.8
mg/l
58.9
62.6
0.09
49
528
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
57
636
0.89
0.34
2.6
3.8
ratio
1.0
1.6
—
9
52
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
10
133
0.75
0.33
1.8
1.6
u/l
6.0
6.8
—
5
71
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
216
2273
0.95
0.32
2.8
2.6
umol/l
7.5
8.1
0.17
186
1990
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
56
502
1.12
0.32
2.0
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
27
229
1.18
0.32
1.4
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
165
0.79
0.32
1.5
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
96
0.73
0.31
1.4
3.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
96
0.73
0.31
1.1
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
54
485
1.12
0.30
3.4
3.0
mmol/l
23.1
25.1
2.69
45
415
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
89
964
0.92
0.30
1.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
99
0.71
0.30
1.1
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
15
120
1.25
0.30
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
56
1.25
0.29
1.0
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
279
2678
1.05
0.29
3.4
2.5
%
24.1
23.1
0.47
247
2278
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1596
16127
0.97
0.29
7.2
7.5
u/l
76.9
78.1
0.57
1527
15147
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
201
2110
0.95
0.29
1.5
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
167
1.20
0.28
1.2
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
28
323
0.87
0.28
1.4
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
115
1227
0.93
0.28
4.8
3.4
ph
7.4
7.4
0.44
15
160
(3016750) Collection duration of Urine
10
129
0.77
0.28
3.3
1.9
min
521.6
494.4
—
10
91
(3022493) Free Hemoglobin [Mass/volume] in Plasma
10
76
1.32
0.28
1.2
6.0
mg/l
60.5
68.5
—
10
50
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
29
333
0.87
0.28
1.1
1.2
u/l
18.3
34.0
1.28
29
281
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
374
3862
0.96
0.27
3.9
3.6
ng/l
487.2
434.9
0.09
306
3023
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
275
2852
0.96
0.25
1.4
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
66
608
1.09
0.25
1.6
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
40
445
0.90
0.25
1.5
1.3
miu/ml
121.5
210.6
1.30
16
195
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
9
75
1.20
0.25
1.0
1.1
—
571.3
—
0
23
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
94
1004
0.93
0.25
1.6
1.7
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
13
105
1.24
0.24
2.5
1.5
u/field
4.4
2.1
—
7
80
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
51
465
1.10
0.24
1.4
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
180
1.17
0.23
1.7
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
147
0.82
0.23
1.3
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
39
1.28
0.23
1.0
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
168
0.83
0.22
2.5
2.2
u/field
1.3
1.7
—
7
69
(3048689) Calprotectin [Mass/mass] in Stool
219
2275
0.96
0.22
1.9
2.2
ug/g
181.4
138.4
0.65
178
1802
(3006315) Basophils [#/volume] in Blood
993
10070
0.98
0.22
6.1
5.7
e9/l
0.0
0.0
0.28
876
8628
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
274
0.87
0.22
1.1
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
41
452
0.91
0.22
5.3
4.3
mmol/l
3.0
2.7
0.37
29
322
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
93
875
1.07
0.22
2.0
1.7
g/l
1.6
1.6
0.31
82
763
(3021387) Prolactin [Units/volume] in Serum or Plasma
49
449
1.09
0.21
1.4
1.6
mu/l
261.2
295.0
0.79
44
413
(3006184) Hemoglobin [Mass/volume] in Capillary blood
42
461
0.91
0.21
2.3
2.2
g/l
127.8
129.6
0.23
25
337
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.1
—
0
6
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.1
—
0
6
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
4940.0
—
0
6
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.0
—
0
6
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
3.1
—
0
5
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
15.4
—
0
10
(3030313) Adrenal Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.1
—
8.1
—
0
12
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
12
0.00
0.21
0.0
2.9
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.1
—
22.2
—
0
12
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
12
0.00
0.21
0.0
5.8
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.1
—
38.1
—
0
12
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
23
201
1.15
0.21
1.8
1.8
—
1616.0
—
0
5
(3019198) Lymphocytes [#/volume] in Blood
1016
10289
0.98
0.20
6.1
5.8
e9/l
1.9
1.9
1.30
903
9003
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
2.1
—
20.5
—
0
14
(3014271) Vancomycin [Susceptibility]
11
90
1.22
0.19
3.5
2.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
22
249
0.88
0.19
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
34
374
0.91
0.19
7.0
3.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
32
353
0.91
0.18
1.3
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
990
10019
0.98
0.18
6.1
5.7
e9/l
0.6
0.6
0.91
869
8589
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
119
1246
0.95
0.18
4.8
3.4
kpa
5.1
5.2
0.26
107
1158
(3000034) Microalbumin [Mass/volume] in Urine
17
195
0.87
0.17
2.4
2.9
mg/l
19.2
32.0
—
10
145
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
7
61
1.15
0.17
1.3
1.2
%
133.3
112.9
—
7
51
(3036071) Salmonella sp Ab [Titer] in Serum
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
16
184
0.87
0.17
3.4
3.5
%
55.9
54.3
—
10
120
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
835
8458
0.98
0.17
2.0
2.0
pmol/l
90.8
95.4
2.10
443
4237
(21491868) Cryoglobulin [Mass/volume] in Serum
10
82
1.22
0.17
1.0
1.3
g/l
—
0.1
—
0
10
(3025130) Human papilloma virus identified in Specimen
23
205
1.12
0.17
1.7
1.8
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
64
680
0.94
0.16
2.0
2.6
g/l
0.4
1.2
1.99
53
594
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
70
0.71
0.16
2.2
2.4
nmol/l
173.2
151.6
—
5
62
(3051611) Lipemic interference index of Serum or Plasma
23
206
1.12
0.16
3.4
3.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
77
0.78
0.15
1.3
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
81
1.11
0.15
1.1
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
21
188
1.12
0.14
1.4
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
50
469
1.07
0.14
1.8
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
306
0.91
0.14
1.2
1.1
u/ml
0.3
1.5
—
5
125
(3023323) Follitropin [Units/volume] in Serum or Plasma
72
684
1.05
0.14
1.3
1.4
iu/l
33.8
35.1
0.12
60
593
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
181
0.88
0.14
1.0
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
8
100
0.80
0.13
1.5
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
13
113
1.15
0.13
1.2
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
43
403
1.07
0.13
1.4
1.2
u/ml
34.6
44.9
—
8
50
(3026782) Osmolality of Urine
395
3883
1.02
0.13
3.4
2.7
mosm/kgh2o
515.0
542.9
1.94
347
3303
(3021960) Folate [Moles/volume] in Serum or Plasma
476
4689
1.02
0.13
1.5
1.5
nmol/l
19.2
21.0
1.85
425
3955
(4062490)
21
190
1.11
0.12
1.4
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
21
231
0.91
0.12
1.1
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
13
114
1.14
0.11
1.2
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
19
172
1.11
0.11
2.8
1.9
%
11.0
10.7
0.16
19
172
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
56
588
0.95
0.11
2.1
2.4
g/l
0.0
0.0
0.19
49
546
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
219
2237
0.98
0.11
3.4
4.3
u/l
246.4
250.3
0.08
209
2107
(3028026) IgM [Mass/volume] in Serum or Plasma
113
1166
0.97
0.11
1.7
1.9
g/l
1.2
1.4
1.17
101
1058
(3004789) Transferrin [Mass/volume] in Serum or Plasma
291
2859
1.02
0.11
3.3
2.4
g/l
2.3
2.3
0.06
270
2646
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
18
163
1.11
0.10
1.3
1.4
u/l
464.6
340.0
0.50
18
156
(3005570) Glucose [Moles/volume] in Urine
21
193
1.09
0.10
1.9
2.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
45
1.11
0.09
4.0
2.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
45
1.11
0.09
1.2
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
106
1.13
0.09
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
106
1.13
0.09
1.1
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
106
1.13
0.09
1.3
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
106
1.13
0.09
1.3
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
106
1.13
0.09
1.3
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
106
1.13
0.09
1.3
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
52
544
0.95
0.09
2.1
2.5
g/l
0.0
0.0
0.00
46
508
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
87
1.15
0.09
1.7
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
87
1.15
0.09
1.7
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
58
556
1.04
0.09
1.5
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1174
11805
0.99
0.09
8.0
9.2
e9/l
4.3
4.0
3.38
1049
10262
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
21
194
1.08
0.09
3.6
3.9
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
5
62
0.81
0.08
1.2
2.3
%
33.2
29.1
—
5
54
(3006245) CD3-CD19+ cells/100 cells in Blood
5
64
0.78
0.08
1.6
2.3
%
12.2
8.9
—
5
55
(3033799) Differential panel - Peritoneal fluid
7
65
1.08
0.08
1.1
1.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
46
441
1.04
0.07
1.2
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
192
1952
0.98
0.07
2.1
2.1
g/l
0.2
0.2
0.09
182
1828
(3039162) Centromere protein B Ab [Units/volume] in Serum
25
235
1.06
0.07
1.7
1.2
u/ml
23.5
37.8
—
5
15
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
88
1.02
0.07
1.2
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
88
1.02
0.07
1.2
1.7
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
53
549
0.96
0.07
2.1
2.5
g/l
0.0
0.0
0.49
46
509
(3000570) Elastase.pancreatic [Mass/mass] in Stool
62
640
0.97
0.07
1.6
1.4
ug/g
291.0
282.5
0.11
42
377
(4211845)
8
93
0.86
0.06
2.1
3.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
128
1.09
0.06
1.1
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
17
183
0.93
0.06
1.1
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
99
1.11
0.06
1.7
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
9
105
0.86
0.06
1.1
1.4
umol/l
19.0
24.7
—
9
100
(1616796) Gas panel - Central venous blood
43
446
0.96
0.06
5.3
3.7
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
12
131
0.92
0.05
1.2
1.3
—
1.4
—
0
7
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
141
0.92
0.05
1.1
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
38
366
1.04
0.05
1.4
1.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
10
110
0.91
0.05
1.7
1.5
ug/l
6.2
7.5
—
10
93
(3005988) Vibrio sp identified in Specimen by Organism specific culture
25
262
0.95
0.04
1.5
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
191
0.94
0.04
1.5
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
745
1.02
0.04
1.9
2.6
g/l
3.0
3.1
0.12
59
585
(3024263) Appearance of Synovial fluid
11
119
0.92
0.04
1.0
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
29
301
0.96
0.03
1.9
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
210
0.95
0.03
1.3
1.3
e6/l
59577.8
87558.6
0.17
14
112
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
794
0.98
0.03
1.9
2.5
g/l
7.4
7.4
0.16
60
602
(40768441) Liver Pathology biopsy report
13
139
0.93
0.03
1.6
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
25
260
0.96
0.03
1.5
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
25
260
0.96
0.03
1.5
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
793
0.98
0.03
1.9
2.5
g/l
3.8
3.8
0.01
58
572
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
793
0.98
0.03
1.9
2.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
112
1.07
0.03
1.2
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
25
241
1.04
0.02
1.4
1.4
e6/l
3920.9
1817.8
0.63
19
168
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
14
132
1.06
0.02
1.1
1.6
umol/l
10.1
13.4
2.02
14
126
(3008401) Mugwort IgE Ab [Units/volume] in Serum
25
258
0.97
0.02
1.1
1.1
u/ml
0.7
1.5
—
8
105
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
26
268
0.97
0.02
1.5
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
42
428
0.98
0.01
3.2
2.6
%
16.5
16.2
0.31
23
224
(40761511) CBC panel - Blood by Automated count
2121
21198
1.00
0.01
16.2
13.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
26
267
0.97
0.01
2.2
2.2
u/ml
8.9
1038.8
0.53
26
258
(3024522) Salmonella sp identified in Specimen by Organism specific culture
26
267
0.97
0.01
1.5
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
423
1.02
0.01
1.3
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
147
1462
1.01
0.01
2.6
3.0
g/l
10.9
10.4
0.50
137
1329
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
313
3138
1.00
0.01
3.2
2.9
e6/l
2.4
2.6
0.14
169
1679
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
30
306
0.98
0.00
1.1
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
40
406
0.98
0.00
3.1
3.0
nmol/l
0.8
0.8
0.01
31
313
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
78
774
1.01
0.00
1.1
1.1
—
0.9
—
0
11
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
13
129
1.01
0.00
1.0
1.0
mg/l
229.7
301.7
1.29
13
113
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
26
265
0.98
0.00
1.5
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
29
285
1.02
0.00
1.5
1.6
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
18
179
1.01
0.00
1.4
1.4
mmol/l
5.5
6.6
1.62
18
164
(3012441) Differential panel - Pleural fluid
19
189
1.01
0.00
1.3
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
37
365
1.01
0.00
3.4
2.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
61
615
0.99
0.00
2.0
2.3
g/l
38.2
38.0
0.09
52
535
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
735
0.99
0.00
1.9
2.6
g/l
9.9
10.2
0.28
60
630
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
11
114
0.96
0.00
1.1
1.4
—
927.1
—
0
7
(4027681)
10
98
1.02
0.00
1.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
50
496
1.01
0.00
1.7
1.9
iu/l
2.9
5.1
2.86
12
174
(3020876) Protein [Mass/time] in 24 hour Urine
19
192
0.99
0.00
2.2
2.1
—
1.3
—
0
5
(3042631) Mycobacterium sp identified in Specimen
27
272
0.99
0.00
1.9
2.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
45
452
1.00
0.00
2.8
3.5
u/ml
668.7
984.5
0.17
45
418
(3003888) Timothy IgE Ab [Units/volume] in Serum
26
263
0.99
0.00
1.1
1.1
u/ml
2.6
3.8
—
10
123
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
112
1123
1.00
0.00
1.7
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
54
0.93
0.00
1.2
1.3
ug/l
8.1
8.7
—
5
54
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
85
0.94
0.00
2.9
4.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
94
0.96
0.00
1.8
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
74
0.95
0.00
1.0
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
55
0.91
0.00
1.0
1.6
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
53
0.94
0.00
2.6
1.1
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
4.5
—
0
5
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
8
84
0.95
0.00
1.0
1.0
—
0.4
—
0
21
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
377.9
—
0
9
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
1.3
—
0
9
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.3
—
711.4
—
0
9
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
6
62
0.97
0.00
1.0
1.5
%
19.5
23.0
—
6
57
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
53
0.94
0.00
2.6
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
12
120
1.00
0.00
1.0
1.1
nmol/l
0.3
5.7
—
5
18
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
79
1.01
0.00
1.6
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
53
0.94
0.00
2.6
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
5
52
0.96
0.00
2.0
2.9
—
45.3
—
0
9
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.0
—
1.2
—
0
5
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
53
0.94
0.00
2.6
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
89
1.01
0.00
1.2
1.7
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
2.8
—
0
6
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
59
1.02
0.00
1.3
1.6
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
85
0.94
0.00
2.1
3.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
58
0.86
0.00
1.0
1.4
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
2.3
—
2.5
—
0
7
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
2.4
—
0
8
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
62
0.97
0.00
1.2
1.8
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
11
110
1.00
0.00
1.1
1.4
—
81.8
—
0
11
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
59
0.85
0.00
1.6
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: I9_ANEUR – Endovascular or surgical operations to intracerebral aneurysms
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).